Background: Treating severe alcoholic hepatitis involves the exposure of patients to corticosteroids for 7 days to assess "response".
Aim: To assess the prognostic and therapeutic implications of baseline neutrophil-to-lymphocyte ratio (NLR) in patients with severe alcoholic hepatitis.
Methods: Patients recruited to the STOPAH trial and an independent validation group were analysed retrospectively.